Bristol Will Repatriate Foreign Cash, Fourth Quarter Charge Expected
This article was originally published in The Pink Sheet Daily
Executive Summary
Bristol-Myers Squibb intends to take full advantage of a new law allowing companies to repatriate cash held by foreign subsidiaries at a reduced tax rate